US Patent Issued to Nano Hesgarsazan Salamat Arya on Jan. 28 for "Deactivation of circulating tumor cells (CTCs) in the bloodstream by electrostatic stimulation of the peripheral blood" (Iranian Inventors)

Posted On: 2025-01-29

ALEXANDRIA, Va., Jan. 29 -- United States Patent no. 12,208,189, issued on Jan. 28, was assigned to Nano Hesgarsazan Salamat Arya (Iran).

"Deactivation of circulating tumor cells (CTCs) in the bloodstream by electrostatic stimulation of the peripheral blood" was invented by Mohammad Abdolahad (Tehran, Iran), Mohammad Reza Ghaderinia (Tehran, Iran), Mohammad Ali Khayamian (Tehran, Iran), Hamed Abadijoo (Tehran, Iran) and Shahriar Shalileh (Tehran, Iran).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for deactivating circulating cancer cells (CTCs). The method includes reducing viability of CTCs and/or destroying CTCs by applying a positive electrostatic field to bloodstream of a cancer patient."

The ...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

US Patent Issued to Nano Hesgarsazan Salamat Arya on Jan. 28 for "Deactivation of circulating tumor cells (CTCs) in the bloodstream by electrostatic stimulation of the peripheral blood" (Iranian Inventors)